Original ArticleDissecting the target leukocyte subpopulations of clinically relevant inflammation radiopharmaceuticals
Introduction
Inflammation plays a major role in cardiovascular pathology and is a promising target for novel gene- and small peptide-based therapies.1,2 Leukocyte infiltration is associated with atherosclerotic plaque vulnerability,3 myocardial infarction,4 cardiac sarcoidosis,5 and progressive heart failure.6 Several specific leukocyte populations participate in the propagation and resolution of tissue inflammation and healing.7 Severity of inflammation can predict functional outcome,8,9 as evidenced by leukocyte count after hospitalization.10,11 But conventional blood-based measurements do not accurately reflect local tissue inflammation.8 Accordingly, non-invasive imaging techniques such as positron emission tomography (PET) are an attractive method to assess tissue inflammation.8
Clinically, inflammation imaging has relied on 18F-FDG, which accumulates in activated macrophages due to high glucose metabolism.12 Uptake of 18F-FDG correlates well with macrophage content in atherosclerotic plaque and infarct tissue.13,14 However, 18F-FDG is not specific for leukocytes, such that high cardiomyocyte signal and requisite myocyte suppression protocols complicate image interpretation.15
In recent years, a range of alternative tracers have been characterized for preclinical and clinical delineation of inflammatory cells, including amino acid metabolism, leukocyte-expressed chemokine receptors, and macrophage-expressed TSPO and SSTR2.13,16, 17, 18 Preclinical and clinical studies using imaging agents targeting these biomarkers have demonstrated specificity of for inflammation.18, 19, 20, 21, 22, 23 However, the range of leukocyte subpopulations and their diverse adverse and protective roles necessitates a closer examination of the precise cellular basis of the imaging signal.
Accordingly, we undertook a side-by-side in vitro comparison of the uptake profile for metabolism-targeted and molecular-targeted inflammation radiotracers in isolated leukocyte subpopulations and polarized macrophages. For comparison, uptake by cardiomyocytes and cardiac fibroblasts was assessed to determine potential contribution to in vivo non-inflammatory signal.
Section snippets
Methods
Additional details are provided in the online supplement.
Validation of Purified Cell Populations
To ensure the maintained health of all cell populations evaluated, metabolic viability of isolated leukocytes and polarized macrophages was tested. Viability between all cell subtypes was comparable. Likewise, exposure to radioactivity dose used in uptake assays did not adversely impact metabolic viability (Online Figure 1A and B). Trypan blue exclusion assay confirmed identical viability at time of assay between M0, M1, M2a, and M2c macrophages (Online Figure 1C). To verify the distinct
Discussion
The range of inflammation-targeted radiotracers has expanded, but specificity for leukocyte subtypes is poorly defined. We evaluated the in vitro binding characteristics of inflammation imaging agents to demonstrate three major findings. First, elevated metabolic rate drives selective uptake of 18F-FDG and labeled amino acids by monocytes and pro-inflammatory M1-like macrophages over other leukocyte subtypes including reparative M2-like macrophages, though metabolic tracers also accumulate in
Limitations
Some limitations of the current study should be considered. First, because uptake assays were conducted using common incubation periods, absolute tracer uptake may be underestimated compared to 18F-FDG. The lower absolute uptake of 68Ga-labeled tracers may be influenced by the shorter radioactive half-life, saturable receptor-limited binding, and rapid turnover of receptors at the cell surface, as we did not account for internalization or efflux of the tracer. Nonetheless, uptake assays for
New Knowledge Gained
Direct comparison of in vitro uptake identified distinct cell populations targeting for clinically validated inflammation PET radiotracers. These cellular substrates provide valuable insights into the suitability of each metabolic or molecular imaging tracer for infiltrative cardiovascular diseases characterized by different dominant leukocyte subtypes, guiding the selection of appropriate imaging markers of inflammatory and reparative macrophages, granulocytes, and lymphocytes.
Conclusion
The present data indicate the variability of the cellular substrate for imaging agents targeting inflammation. Importantly, the optimal radiotracer for post-infarct or atherosclerotic plaque inflammation may be different from post-transplant rejection or sarcoidosis imaging. The temporal pattern of tracer retention and specific targeting of leukocyte subtypes can provide critical insights into disease progression and response to therapy. Different inflammation radiotracers target divergent
Acknowledgments
This study was supported by the German Research Foundation (DFG, Clinical Research Group KFO311, Excellence Cluster REBIRTH-2, and research Grant TH-2161/1-1 (JT)). The authors thank the Preclinical Molecular Imaging Core Facility, Radiochemistry Laboratory, and the Molecular Cardiology Laboratory for skilled assistance.
Disclosure
All authors declare that they have no conflict of interest.
References (42)
- et al.
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Trends Pharmacol Sci
(2003) - et al.
Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling
J Am Coll Cardiol
(2002) - et al.
Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity
Hum Immunol
(2018) - et al.
The neonate versus adult mammalian immune system in cardiac repair and regeneration
Biochim Biophys Acta
(2016) - et al.
Molecular imaging of myocardial inflammation with positron emission tomography post-ischemia: A determinant of subsequent remodeling or recovery
JACC Cardiovasc Imaging
(2018) - et al.
Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction
Am J Cardiol
(2010) - et al.
Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice
Am J Pathol
(2007) - et al.
Visualizing cancer and immune cell function with metabolic positron emission tomography
Curr Opin Genet Dev
(2010) - et al.
Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study
Lancet
(2017) - et al.
Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction
J Am Coll Cardiol
(2018)
Molecular imaging of the chemokine receptor CXCR18 after acute myocardial infarction
JACC Cardiovasc Imaging
Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice
Atherosclerosis
Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques
JACC Cardiovasc Imaging
Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging
J Am Coll Cardiol
Significant mobilization of both conventional and regulatory T cells with AMD3100
Blood
THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro
Mol Immunol.
Application of transcription factor “decoy” strategy as means of gene therapy and study of gene expression in cardiovascular disease
Circ Res
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture
Circulation
Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure
Circ Res
Prospective evaluation of 18F-fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography/magnetic resonance imaging as a prognostic marker of functional outcome
Circ Cardiovasc Imaging
Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model
Eur J Nucl Med Mol Imaging
Cited by (34)
Update on imaging in fever and inflammation of unknown origin: focus on infectious disorders
2024, Clinical Microbiology and InfectionRadionuclide Imaging of Heart-Brain Connections
2023, Cardiology Clinics[<sup>99m</sup>Tc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience
2023, European Journal of Nuclear Medicine and Molecular ImagingControl of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
2023, Drug Delivery and Translational ResearchTracers for Cardiac Imaging: Targeting the Future of Viable Myocardium
2023, Pharmaceutics
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarizes the contents of the article and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.
The authors have also provided an audio summary of the article, which is available to download as ESM, or to listen to via the JNC/ASNC Podcast.